I thought someone might call me out on that (actually I thought it would be OPC). The reason I "discount" it is becasue I always assumed they would do a phase 4 study to expand the label following type 2 approval. So, it is not as much a matter of whether the label is expanded, but when.

At this juncture, my (overweighted) investment is divided into 3 parts: 20% to be sold prior to pdufa and 40% to be sold following approval and 40% to be held post partner.